Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

 Dow Down 1.51% Nasdaq  0.00%
Alexion Pharmaceuticals, Inc. (ALXN)On May 14: 52.12   0.00 (0.00%)  
More on ALXN
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
Total Revenue 386,800   259,099   72,041  
Cost of Revenue45,059  28,366  6,696  
Gross Profit 341,741   230,733   65,345  
Operating Expenses
Research Development81,915  62,581  68,961  
Selling General and Administrative172,767  133,543  96,142  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 87,059   34,609   (99,758)
Income from Continuing Operations
Total Other Income/Expenses Net(3,139)2,528  9,212  
Earnings Before Interest And Taxes83,920  37,137  (90,546)
Interest Expense606  2,407  2,489  
Income Before Tax83,314  34,730  (93,035)
Income Tax Expense(211,852)1,581  (745)
Minority Interest -   -   -  
Net Income From Continuing Ops295,166  33,149  (92,290)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 295,166   33,149   (92,290)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares $295,166   $33,149   ($92,290)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More